Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dermata Therapeutics Inc (NQ: DRMA )

4.200 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,903
Open 4.200
Bid (Size) 4.400 (1)
Ask (Size) 4.700 (10)
Prev. Close 4.200
Today's Range 4.200 - 4.200
52wk Range 0.2320 - 5.790
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Dermata Therapeutics Announces Exercise of Warrants for $2.66 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules
Via ACCESSWIRE
DRMA Stock Earnings: Dermata Therapeutics Misses EPS for Q1 2024
DRMA stock results show that Dermata Therapeutics missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace

Performance

YTD
+611.74%
+611.74%
1 Month
+1208.00%
+1208.00%
3 Month
+848.94%
+848.94%
6 Month
+403.36%
+403.36%
1 Year
+85.84%
+85.84%

More News

Read More
Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
Via ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Dermata to Present at the Emerging Growth Conference on April 3, 2024
Via ACCESSWIRE
Dermata to Present at the Emerging Growth Conference on February 7, 2024
Via ACCESSWIRE
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
DRMA Stock Earnings: Dermata Therapeutics Reported Results for Q4 2023
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Dow Turns Lower; ISM Services PMI Falls In December
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Aesthetic Skin Conditions-Focused Dermata Therapeutics Stock Trading Higher Today?
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Why Is Applied Therapeutics (APLT) Stock Down 30% Today?
Via InvestorPlace
Why Is CISO Global (CISO) Stock Down 14% Today?
Via InvestorPlace
Why Is Dermata Therapeutics (DRMA) Stock Up 62% Today?
Via InvestorPlace
Topics Intellectual Property
Exposures Intellectual Property
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Dermata Therapeutics Shares Are Trading Higher By Over 57%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Dermata Expands Global Intellectual Patent Portfolio with Issuance of Japanese Patent for DMT410 for the Treatment of Hyperhidrosis
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.